These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32194703)

  • 1. Elevated expression of exosomal microRNA-21 as a potential biomarker for the early diagnosis of pancreatic cancer using a tethered cationic lipoplex nanoparticle biochip.
    Pu X; Ding G; Wu M; Zhou S; Jia S; Cao L
    Oncol Lett; 2020 Mar; 19(3):2062-2070. PubMed ID: 32194703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An elevated expression of serum exosomal microRNA-191, - 21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker.
    Goto T; Fujiya M; Konishi H; Sasajima J; Fujibayashi S; Hayashi A; Utsumi T; Sato H; Iwama T; Ijiri M; Sakatani A; Tanaka K; Nomura Y; Ueno N; Kashima S; Moriichi K; Mizukami Y; Kohgo Y; Okumura T
    BMC Cancer; 2018 Jan; 18(1):116. PubMed ID: 29385987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive Detection of Exosomal MicroRNAs via Tethered Cationic Lipoplex Nanoparticles (tCLN) Biochip for Lung Cancer Early Detection.
    Liu C; Kannisto E; Yu G; Yang Y; Reid ME; Patnaik SK; Wu Y
    Front Genet; 2020; 11():258. PubMed ID: 32265989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma-Derived Exosomal ALIX as a Novel Biomarker for Diagnosis and Classification of Pancreatic Cancer.
    Yang J; Zhang Y; Gao X; Yuan Y; Zhao J; Zhou S; Wang H; Wang L; Xu G; Li X; Wang P; Zou X; Zhu D; Lv Y; Zhang S
    Front Oncol; 2021; 11():628346. PubMed ID: 34026608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Intergenic Non-Coding 00162 as Diagnostic Biomarker for Early-Stage Pancreatic Cancer.
    Chen M; Lu Y; Qin S; Hu Z; Chen H; Lu L; Mo C; Zhang X; Huang J; Qin X
    Ann Clin Lab Sci; 2022 Jul; 52(4):533-543. PubMed ID: 36197769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal miR-200 family as serum biomarkers for early detection and prognostic prediction of cholangiocarcinoma.
    Shen L; Chen G; Xia Q; Shao S; Fang H
    Int J Clin Exp Pathol; 2019; 12(10):3870-3876. PubMed ID: 31933776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
    Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
    Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Exosomal miR-422a and miR-125b-2-3p Serve as Biomarkers for Ischemic Stroke.
    Li DB; Liu JL; Wang W; Li RY; Yu DJ; Lan XY; Li JP
    Curr Neurovasc Res; 2017; 14(4):330-337. PubMed ID: 28982331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrafast Detection of Exosomal RNAs
    Yang Y; Kannisto E; Patnaik SK; Reid ME; Li L; Wu Y
    ACS Appl Nano Mater; 2021 Mar; 4(3):2806-2819. PubMed ID: 34849458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of circulating exosomal biomarkers and their diagnostic accuracy in pancreatic cancer.
    Sha M; Kunduzi B; Froghi S; Quaglia A; Davidson B; Fusai GK
    JGH Open; 2023 Jan; 7(1):30-39. PubMed ID: 36660044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum miR-1290 and miR-1246 as Potential Diagnostic Biomarkers of Human Pancreatic Cancer.
    Wei J; Yang L; Wu YN; Xu J
    J Cancer; 2020; 11(6):1325-1333. PubMed ID: 32047539
    [No Abstract]   [Full Text] [Related]  

  • 13. Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer.
    Lin MS; Chen WC; Huang JX; Gao HJ; Sheng HH
    Int J Clin Exp Med; 2014; 7(12):5226-34. PubMed ID: 25664025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.
    Hussein NA; Kholy ZA; Anwar MM; Ahmad MA; Ahmad SM
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):83-93. PubMed ID: 27631726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miR-629 is a novel molecular marker for diagnosis and the prognosis of pancreatic cancer.
    Shi W; Lu Y; Gong R; Sun JJ; Liu G
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5187-5193. PubMed ID: 30178840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma.
    Cho HJ; Eun JW; Baek GO; Seo CW; Ahn HR; Kim SS; Cho SW; Cheong JY
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31968558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer.
    Pang L; Zhang N; Xia Y; Wang D; Wang G; Meng X
    Oncotarget; 2016 Nov; 7(47):77854-77864. PubMed ID: 27788483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating lncRNA ABHD11-AS1 serves as a biomarker for early pancreatic cancer diagnosis.
    Liu Y; Feng W; Liu W; Kong X; Li L; He J; Wang D; Zhang M; Zhou G; Xu W; Chen W; Gong A; Xu M
    J Cancer; 2019; 10(16):3746-3756. PubMed ID: 31333792
    [No Abstract]   [Full Text] [Related]  

  • 20. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
    Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
    Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.